Suchergebnisse - "Irina Bonzheim"

PubPharm (13)

1

Image‐guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake

in: Clinical and Translational Medicine | 2024

von Qianlu Yang | Sisi Deng | Heike Preibsch | +14

2

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

in: Nature Communications | 2022

von Jens Bauer | Natalie Köhler | Yacine Maringer | +26

3

Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification

in: International Journal of Molecular Sciences | 2022

von Ivonne A. Montes-Mojarro | Saki Hassas | Sina Staehle | +7

4

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies

in: Cancers | 2021

von Magdalena M. Brune | Achim Rau | Mathis Overkamp | +7

5

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

in: Frontiers in Oncology | 2021

von Andrea Forschner | Tobias Sinnberg | Tobias Sinnberg | +17

6

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

in: Nature Communications | 2021

von Fabian Frontzek | Annette M. Staiger | Myroslav Zapukhlyak | +41

7

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

in: Cancers | 2020

von Andrea Forschner | Franz-Joachim Hilke | Irina Bonzheim | +12

8

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

in: Cancers | 2020

von Franz J. Hilke | Tobias Sinnberg | Axel Gschwind | +10

9

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications

in: BMC Medical Genetics | 2018

von Markus W. Löffler | Julia Steinhilber | Franz J. Hilke | +14

10

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

in: OncoImmunology | 2017

von Annika Nelde | Juliane Sarah Walz | Daniel Johannes Kowalewski | +14